These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2667487)

  • 41. Fucosylated chondroitin sulfate from sea cucumber improves glucose metabolism and activates insulin signaling in the liver of insulin-resistant mice.
    Hu SW; Tian YY; Chang YG; Li ZJ; Xue CH; Wang YM
    J Med Food; 2014 Jul; 17(7):749-57. PubMed ID: 24949837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of galanin on hormone secretion from the in situ perfused rat pancreas and on glucose production in rat hepatocytes in vitro.
    Silvestre RA; Miralles P; Monge L; Moreno P; Villanueva ML; Marco J
    Endocrinology; 1987 Jul; 121(1):378-83. PubMed ID: 2439313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats.
    Li PP; Shan S; Chen YT; Ning ZQ; Sun SJ; Liu Q; Lu XP; Xie MZ; Shen ZF
    Br J Pharmacol; 2006 Jul; 148(5):610-8. PubMed ID: 16751799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidiabetic activity of Ganoderma lucidum polysaccharides F31 down-regulated hepatic glucose regulatory enzymes in diabetic mice.
    Xiao C; Wu Q; Zhang J; Xie Y; Cai W; Tan J
    J Ethnopharmacol; 2017 Jan; 196():47-57. PubMed ID: 27902927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Divergent effects of oxytocin treatment of obese diabetic mice on adiposity and diabetes.
    Altirriba J; Poher AL; Caillon A; Arsenijevic D; Veyrat-Durebex C; Lyautey J; Dulloo A; Rohner-Jeanrenaud F
    Endocrinology; 2014 Nov; 155(11):4189-201. PubMed ID: 25157455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of the oral hypoglycemic agent pirogliride (McN-3495) on glycogen levels of normal and diabetic rats.
    Tutwiler GF; Fawthrop H
    Biochem Int; 1983 Jul; 7(1):55-62. PubMed ID: 6383388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological studies on -guanidinobutyramide.
    Buckle AL; Jones HE
    Horm Metab Res; 1971 Mar; 3(2):76-81. PubMed ID: 4941848
    [No Abstract]   [Full Text] [Related]  

  • 49. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
    Cam MC; Brownsey RW; Rodrigues B; McNeill JH
    Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ-db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway.
    You HN; Park MH; Hwang SY; Han JS
    J Med Food; 2018 Apr; 21(4):324-331. PubMed ID: 29630449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison on hypoglycemic and antioxidant activities of the fresh and dried Portulaca oleracea L. in insulin-resistant HepG2 cells and streptozotocin-induced C57BL/6J diabetic mice.
    Gu JF; Zheng ZY; Yuan JR; Zhao BJ; Wang CF; Zhang L; Xu QY; Yin GW; Feng L; Jia XB
    J Ethnopharmacol; 2015 Feb; 161():214-23. PubMed ID: 25523372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic ALT isoenzymes are elevated in gluconeogenic conditions including diabetes and suppressed by insulin at the protein level.
    Qian K; Zhong S; Xie K; Yu D; Yang R; Gong DW
    Diabetes Metab Res Rev; 2015 Sep; 31(6):562-71. PubMed ID: 25865565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Des-aspartate-angiotensin I exerts hypoglycemic action via glucose transporter-4 translocation in type 2 diabetic KKAy mice and GK rats.
    Sim MK; Xu XG; Wong YC; Sim SZ; Lee KO
    Endocrinology; 2007 Dec; 148(12):5925-32. PubMed ID: 17823251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ciglitazone, a new hypoglycaemic agent. 3. Effect on glucose disposal and gluconeogenesis in vivo in C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Gilchrist BJ; Wyse BM
    Diabetologia; 1983 Dec; 25(6):514-20. PubMed ID: 6662280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipogenic action of the novel oral antidiabetic agent HQL-975 in genetically obese diabetic KK-Ay mice.
    Ishikawa Y; Takeno H; Watanabe K; Tani T
    Biol Pharm Bull; 1999 Jun; 22(6):572-6. PubMed ID: 10408228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extract isolated from Angelica hirsutiflora with insulin secretagogue activity.
    Leu YL; Chen YW; Yang CY; Huang CF; Lin GH; Tsai KS; Yang RS; Liu SH
    J Ethnopharmacol; 2009 Jun; 123(2):208-12. PubMed ID: 19429364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
    Rossetti L; Giaccari A; Barzilai N; Howard K; Sebel G; Hu M
    J Clin Invest; 1993 Sep; 92(3):1126-34. PubMed ID: 8397219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ciglitazone, a hypoglycemic agent: early effects on the pancreatic islets of ob/ob mice.
    Colca JR; Wyse BM; Sawada G; Jodelis KS; Connell CL; Fletcher-McGruder BL; Palazuk BJ; Diani AR
    Metabolism; 1988 Mar; 37(3):276-80. PubMed ID: 3278192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat.
    Narasimhan A; Chinnaiyan M; Karundevi B
    Appl Physiol Nutr Metab; 2015 Aug; 40(8):769-81. PubMed ID: 26201855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.